Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
15 results
  • Melanoma, Kidney Cancer, Lung Cancer, Bladder Cancer, Lymphoma

21-481          Phase I

A First-in-Human, Multicenter, Open-Label, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAB004 as Monotherapy and in Combination with Toripalimab in Subjects with Advanced Solid Malignancies including Lymphoma (View details on

  • Head and Neck Cancer, Bladder Cancer, Melanoma, Lung Cancer

18-418          Phase III

A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial. (View details on

  • Bladder Cancer

20-531          Phase II

A Multicenter, Single-Arm Open Label Phase II Trial of Cryoablation in Combination with Pembrolizumab in Patients with Metastatic Urothelial Carcinoma (View details on

  • Bladder Cancer, Metastatic/Advanced Cancer, Melanoma, Lung Cancer, Head and Neck Cancer

17-330          Phase I

A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors (View details on

  • Lung Cancer, Ovarian Cancer, Melanoma, Uterine Cancer, Bladder Cancer, Endometrial Cancer, Breast Cancer

22-430          Phase II

A Phase 1/2 First-in-Human Study of the Safety and Efficacy of IMC-F106C as a Single Agent and in Combination with Checkpoint Inhibitors in HLA-A*02:01-Positive Participants with Advanced PRAME-Positive Cancers (View details on

  • Sarcoma, Bladder Cancer, Liver Cancer, Gastric (Stomach) Cancer, Endometrial Cancer, Esophageal Cancer, Pancreatic Cancer

20-544          Phase II

A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Advanced Solid Tumors Harboring a p53 Y220C Mutation (View details on

  • Melanoma, Lung Cancer, Bladder Cancer, Head and Neck Cancer, Kidney Cancer, Breast Cancer, Ovarian Cancer

21-329          Phase II

A Phase 1a Open-Label, Dose-Escalation, and a Phase 2 Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of ST-067 Administered Subcutaneously as Monotherapy in Patients with Relapsed or Refractory Solid Tumors (View details on

  • Bladder Cancer, Endometrial Cancer, Chordoma, Cervical Cancer, Ovarian Cancer, Esophageal Cancer, Breast Cancer, Lung Cancer, Pancreatic Cancer, Melanoma

20-650          Phase II

A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Trastuzumab Deruxtecan (T-DXd) for the Treatment of Unresectable and/or Metastatic Solid Tumors Harboring HER2 Activating Mutations Regardless of Tumor Histology (View details on

  • Lung Cancer, Lymphoma, Bladder Cancer, Head and Neck Cancer

19-500          Phase I

An Open-Label, Multicenter, First-in-Human, Dose-Escalation, Phase 1 Study of INBRX-105 in Patients with Locally Advanced or Metastatic Solid Tumors, Hodgkin or Non-Hodgkin Lymphoma (View details on

Showing 1 - 10 of 15 results